A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants
Clinical trial NCT04228783 · COMPLETED
Trial details
- NCT number
- NCT04228783
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2022-04-25
- Enrollment
- 974
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.